263 related articles for article (PubMed ID: 16903165)
21. Prevention and treatment of the metabolic syndrome.
Daskalopoulou SS; Mikhailidis DP; Elisaf M
Angiology; 2004; 55(6):589-612. PubMed ID: 15547646
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
Amihăesei IC; Chelaru L
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
[TBL] [Abstract][Full Text] [Related]
23. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
24. [How to treat dyslipidemia in patients with metabolic syndrome].
Soška V
Vnitr Lek; 2015; 61(7-8):721-4. PubMed ID: 26375703
[TBL] [Abstract][Full Text] [Related]
25. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan.
Hammad EA; Yasein N; Tahaineh L; Albsoul-Younes AM
J Manag Care Pharm; 2011 May; 17(4):295-303. PubMed ID: 21534640
[TBL] [Abstract][Full Text] [Related]
26. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome.
Lien LF; Brown AJ; Ard JD; Loria C; Erlinger TP; Feldstein AC; Lin PH; Champagne CM; King AC; McGuire HL; Stevens VJ; Brantley PJ; Harsha DW; McBurnie MA; Appel LJ; Svetkey LP
Hypertension; 2007 Oct; 50(4):609-16. PubMed ID: 17698724
[TBL] [Abstract][Full Text] [Related]
27. Treatment options for patients with the metabolic syndrome.
Berra K
J Am Acad Nurse Pract; 2003 Aug; 15(8):361-70. PubMed ID: 14509101
[TBL] [Abstract][Full Text] [Related]
28. The metabolic syndrome, hyperlipidemia, and insulin resistance.
Fonseca VA
Clin Cornerstone; 2005; 7(2-3):61-72. PubMed ID: 16473262
[TBL] [Abstract][Full Text] [Related]
29. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
Pennell P; Leclercq B; Delahunty MI; Walters BA
Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
[TBL] [Abstract][Full Text] [Related]
30. Should all patients with metabolic syndrome be treated with statins?
Abate N; Chandalia M
Curr Diab Rep; 2006 Feb; 6(1):72-6. PubMed ID: 16522284
[TBL] [Abstract][Full Text] [Related]
31. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
32. New therapeutic options in the National Cholesterol Education Program Adult Treatment Panel III.
Talbert RL
Am J Manag Care; 2002 Sep; 8(12 Suppl):S301-7. PubMed ID: 12240701
[TBL] [Abstract][Full Text] [Related]
33. Management of dyslipidemia in patients with metabolic syndrome.
Cziraky MJ
J Am Pharm Assoc (2003); 2004; 44(4):478-88; quiz 489-90. PubMed ID: 15372869
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
[TBL] [Abstract][Full Text] [Related]
35. Impact of a one-year lifestyle modification program on cholesterol efflux capacities in men with abdominal obesity and dyslipidemia.
Boyer M; Mitchell PL; Poirier P; Alméras N; Tremblay A; Bergeron J; Després JP; Arsenault BJ
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E460-E468. PubMed ID: 29870675
[TBL] [Abstract][Full Text] [Related]
36. Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy).
Gurrola-Díaz CM; García-López PM; Sánchez-Enríquez S; Troyo-Sanromán R; Andrade-González I; Gómez-Leyva JF
Phytomedicine; 2010 Jun; 17(7):500-5. PubMed ID: 19962289
[TBL] [Abstract][Full Text] [Related]
37. The metabolic syndrome - What is it and how should it be managed?
Nilsson PM; Tuomilehto J; Rydén L
Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):33-46. PubMed ID: 31766917
[TBL] [Abstract][Full Text] [Related]
38. Role of the National Cholesterol Education Program Adult treatment panel III guidelines in managing dyslipidemia.
Talbert RL;
Am J Health Syst Pharm; 2003 Jul; 60(13 Suppl 2):S3-8; quiz S25. PubMed ID: 12901024
[TBL] [Abstract][Full Text] [Related]
39. The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.
Diamantopoulos EJ; Athyros VG; Yfanti GK; Migdalis EN; Elisaf M; Vardas PE; Manolis AS; Karamitsos DT; Ganotakis ES; Hatseras D;
Angiology; 2005; 56(6):731-41. PubMed ID: 16327950
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome: controversial but useful.
Stolar M
Cleve Clin J Med; 2007 Mar; 74(3):199-202, 205-8. PubMed ID: 17375800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
